Cardiovascular Outcome Trial Update in Diabetes: New Evidence, Remaining Questions-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Cardiovascular Outcome Trial Update in Diabetes: New Evidence, Remaining Questions

Published:2017-07-19 Issue:9 Volume:17 Page:
ISSN:1534-4827
Container-title:Current Diabetes Reports
language:en
Short-container-title:Curr Diab Rep

Author:

Herbst Rebecca,Bolton Wilburn,Shariff Afreen,Green Jennifer B.

Publisher

Springer Science and Business Media LLC

Subject

Endocrinology, Diabetes and Metabolism,Internal Medicine

Link

http://link.springer.com/article/10.1007/s11892-017-0898-8/fulltext.html

Reference36 articles.

1. Seshasai SR, Kaptoge S, Thompson A, Di Angelantonio E, Gao P, et al. Diabetes mellitus, fasting glucose and risk of cause specific death. N Engl J Med. 2011;364(9):829–41. doi: 10.1056/NEJMoa1008862 .

2. UK Prospective Diabetes Study (UKPDS) Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet. 1998;352(9131):837–53. doi: 10.1016/S0140-6736(98)07019-6 .

3. Holman RR, Paul SK, Bethel MA, Matthews DR, Neil HA. 10-year follow-up of intensive glucose control in typediabetes. N Engl J Med. 2008;359(15):1577–89. doi: 10.1056/NEJMoa0806470 .

4. Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med. 1993;329:977–86. doi: 10.1056/NEJM199309303291401 .

5. Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Research Group. Retinopathy and nephropathy in patients with type 1 diabetes four years after a trial of intensive therapy. N Engl J Med. 2000;342:381–9. doi: 10.1056/NEJM200002103420603 .

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Glucose-lowering therapy in patients undergoing percutaneous coronary intervention;EuroIntervention;2021-10

2. Guía ESC 2019 sobre diabetes, prediabetes y enfermedad cardiovascular, en colaboración con la European Association for the Study of Diabetes (EASD);Revista Española de Cardiología;2020-05

3. 2019 ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD;European Heart Journal;2019-08-31

4. Cardiodiabesity and Related Updates;Therapeutic Innovation & Regulatory Science;2018-01

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3